2-Day Virtual Seminar on Best Practices for Import and Export Control and Customs Compliance Recorded Webinar | Casper Uldriks | From: Mar 31, 2021 - To: Dec 31, 2021 |
2-Day Virtual Seminar on Best Practices for Import and Export Control and Customs Compliance During and After COVID 19
FDA’s import and export programs are complex, detailed, and undergo changes without notice to the public. The FDA’s and CBP’s new import and enforcement programs operate with remarkably efficient software systems that can leave a firm scrambling for a resolution and end up suffering the expensive consequences of detention. The information database used by the FDA includes extensive information from foreign suppliers. If that is not in order, your shipment will not be permitted entry, in some cases even before the products can be loaded onto the vessel in a foreign port or before it arrives at the U.S. port.
Foreign establishments are subject to the same manufacturing regulations as U.S. firms. There are inherent problems with foreign commerce, such as language and cultural differences. If a foreign firm’s manufacturing operation or its products fail any criteria, detention, or even worse, a refusal, becomes your next crisis. If your product is detained, you must know how to try and resolve the problem with the FDA. You have only ten days to figure out your plan and have FDA agree, which is not a given. On day 11, your product must either be destroyed or exported.
FDA offers special programs to automatically release entries provided pre-qualification criteria are met. This is especially valuable to importers of perishable goods.
Import/export requirements can be confusing and costly if you do not understand the legal requirements. You need clarity, accurate knowledge, and solid business procedures to succeed.
Areas Covered in the Session:-
Why you Should Attend?
Who Will Benefit?
Casper (Cap) Uldriks, through his firm "Encore Insight LLC," brings over 32 years of experience from the FDA. He specialized in the FDA's medical device program as a field investigator, served as a senior manager in the Office of Compliance and an Associate Center Director for the Center for Devices and Radiological Health.
He developed enforcement actions and participated in the implementation of new statutory requirements. His comments are candid, straightforward and of practical value. He understands how FDA thinks, how it operates and where it is headed.
Based on his exceptionally broad experience and knowledge, he can synthesize FDA's domestic and international operational programs, institutional policy and thicket of legal variables into a coherent picture. Professional credentials: JD - Suffolk University, licensed in Massachusetts and the District of Columbia; M.Div in psychology - Boston University with internship through Harvard University.